🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Tirzepatide and sulfur burps: GIP receptor-mediated gastric effects — looking for input Page 4

Tirzepatide and sulfur burps: GIP receptor-mediated gastric effects — looking for input

MaxMetOK Wed, Feb 18, 2026 at 6:56 AM 27 replies 997 viewsPage 4 of 6
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Feb 19, 2026 at 6:02 AM#16
LipidDoc_ATL said:
Dose-response modeling for tirzepatide: Emax model fitting to the STEP/SURMOUNT dose-finding data shows: Semaglutide: ED50 ≈ 0.6mg, Emax ≈ -18%, Hill…

Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything. If your problem is the aversion rather than the fullness, waiting does less, because the aversion is central and it is the mechanism working as intended.

32 5hyun_seoul, jim_asheville, matt_MKE and 29 others
Reply Quote Save Share Report
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Feb 19, 2026 at 8:18 AM#17
Dr.PeteFamMed said:
Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything.

Can confirm. Same sequence, different timescale. Nothing to add that would improve it.

33 6NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 30 others
Reply Quote Save Share Report
LeilaHI
Member
167
789
Jan 2025
Honolulu, HI
Feb 19, 2026 at 10:34 AM#18
Dr.PeteFamMed said:
Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything.

There is a second half to this that has not been said yet. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

34 7mike_nyc, VendorMark, COA_Karl and 31 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Feb 19, 2026 at 12:50 PM#19

One concrete data point for the thread. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

35 8ben_calgary, patPC_UT, Dr.DermMIA and 32 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 19, 2026 at 3:06 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Report rather than reply if it drifts again.

Last edited: Feb 19, 2026 at 5:06 PM
7 5PurityPaulOR, MaxMetOK, MounjBrad and 4 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register